Weight loss drugs and artificial intelligence have been dominating headlines, with investors betting that stocks in both categories have big potential upside.
On Wednesday's Pro Talks , CNBC's Senior Technology Correspondent Arjun Kharpal will ask Tema ETFs' Yuri Khodjamirian how to best invest in these areas and more.
Tema ETFs offers actively managed ETFs, with a focus on healthcare and life sciences.
Before Tema ETFs, Khodjamirian spent over a decade at Majedie Asset Management, overseeing U.K. and global portfolios.
Click here to join CNBC Pro Talks on Wednesday, July 17, at 7 a.m.
Persons:
Arjun Kharpal, Yuri Khodjamirian, Eli Lilly, he'll, Khodjamirian
Organizations:
Tema, Novo Nordisk, pharma, Majedie Asset Management, Income, CNBC, Nvidia, Scotiabank
Locations:
Tema, —, U.S, U.K, India